Outcomes of SGLT-2 Inhibitor induced Euglycaemic Diabetic Ketoacidosis in North Queensland Intensive Care Units: a Retrospective Cohort Study

James Cook University
Leanne Hall
Role

Supervisor

Description

This study will examine all ICU outcomes, including but not limited to; mortality, length of stay, use of ventilator, pertaining to SGLT-2 inhibitor induced euglycaemic ketoacidosis over a period of 8 years at the nominated study sites. A secondary aim will be to compare these findings to ICU outcomes of diabetic ketoacidosis patients, sex/age/co-morbidity matched. The data will be analysed to primarily determine differences between both groups, with the aim to develop an understanding of the unique natural history and risk factors of euglycaemic ketoacidosis.

Date

01 Jun 2024 - 31 May 2026

Project Type

NON_FUNDED_PROJECT

Keywords

N/A

Funding Body

James Cook University

Amount

0

Project Team

N/A